ClinicalTrials.Veeva

Menu

Parasternal Blockade and Serum Lactate in Cardiac Surgery

I

Instituto Mexicano del Seguro Social

Status

Enrolling

Conditions

Elective Cardiac Surgery

Treatments

Procedure: Parasternal block
Procedure: Requirement of total dose regarding fentanyl

Study type

Interventional

Funder types

Other

Identifiers

NCT06516432
Parasternal Blockade 2024

Details and patient eligibility

About

Serum lactate level is a key indicator of tissue perfusion. Parasternal blockade is associated with reduced postoperative inflammatory response by inhibiting stress response, leading to better outcomes. Elevated lactate levels help identify patients at risk of postoperative morbidity and mortality. This analytical cross-sectional study evaluated the association between parasternal blockade and serum lactate levels in patients undergoing elective cardiac surgery in 2022 at Specialty Hospital CMNO. Patients with and without parasternal block were compared for changes in serum lactate levels during and after anesthesia within the first 24 hours.

Full description

Background: Serum lactate level is a crucial indicator of tissue perfusion. Parasternal blockade has been related to a reduction of the postoperative inflammatory response, by inhibition of the stress response, leading to a better prognosis. Increased lactate level is a useful parameter in the identification of patients at risk of postoperative morbidity and mortality.

Objective: To evaluate the association between parasternal blockade and serum lactate level in patients undergoing cardiac surgery, both trans and postanesthesia.

Materials and Methods: Analytical cross-sectional study in adult patients undergoing elective cardiac surgery during the year 2022 in Specialty Hospital CMNO, patients with and without application of parasternal block were analyzed, and it was associated with changes in serum lactate level trans and post anesthesia in the first 24 hours. Approval registration: R-2023-1301-024.

Enrollment

86 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients older than 18 years
  • Either sex
  • ASA II-III
  • Patients who underwent cardiac surgery with median sternotomy and use of cardiopulmonary bypass.

Exclusion criteria

  • Patients with pre-existing conditions that could independently affect serum lactate levels.

Trial design

Primary purpose

Supportive Care

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

86 participants in 2 patient groups

Case group
Experimental group
Description:
with parasternal block
Treatment:
Procedure: Requirement of total dose regarding fentanyl
Procedure: Parasternal block
Control group
No Intervention group
Description:
without parasternal block

Trial contacts and locations

1

Loading...

Central trial contact

Alejandro Gonzalez, 3; Clotilde Fuentes, 1

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems